Back
AN2 Therapeutics Vs. FibroGen Industry Stock Comparison
Sell
48
ANTX
AN2 Therapeutics
Last Price:
1.35
Seasonality Move:
-36.32%
Buy
54
FGEN
FibroGen
Last Price:
0.39
Seasonality Move:
50.95%
Sell
48
AN2 Therapeutics (ANTX)
is a Sell
Is AN2 Therapeutics a Buy, Sell or Hold?
- The current AN2 Therapeutics [ANTX] share price is $1.34. The Score for ANTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ANTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
FibroGen (FGEN)
is a Buy
Is FibroGen a Buy, Sell or Hold?
- The current FibroGen [FGEN] share price is $0.40. The Score for FGEN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- FGEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANTX Stock Price Chart
What is AN2 Therapeutics's stock price today?
-
The AN2 Therapeutics share price today is $1.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANTX is experiencing slight buying pressure.
ANTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 72.02 | Buy |
| Chaikin Money Flow: | 4705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.18) | Buy |
| Bollinger Bands (100): | (0.78 - 2.14) | Sell |
FGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 59.33 | Buy |
| Chaikin Money Flow: | 410142 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.3 - 0.36) | Buy |
| Bollinger Bands (100): | (0.23 - 0.77) | Sell |
ANTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Buy |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.07 | Buy |
| 200-day SMA: | 2.15 | Sell |
| 8-day EMA: | 1.17 | Buy |
| 20-day EMA: | 1.12 | Buy |
| 50-day EMA: | 1.16 | Buy |
| 200-day EMA: | 3.51 | Sell |
FGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.36 | Buy |
| 20-day SMA: | 0.33 | Buy |
| 50-day SMA: | 0.36 | Buy |
| 200-day SMA: | 1.02 | Sell |
| 8-day EMA: | 0.36 | Buy |
| 20-day EMA: | 0.35 | Buy |
| 50-day EMA: | 0.38 | Buy |
| 200-day EMA: | 1.22 | Sell |
AN2 Therapeutics Earnings Growth & ANTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.
FibroGen Earnings Growth & FGEN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $0.48 per share.
AN2 Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
FibroGen Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||